Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
MAAIS
2 other identifiers
observational
2,400
1 country
1
Brief Summary
The investigators are doing the research to discover genes that cause Inflammatory Bowel Disease (IBD) specifically in the African American population. African Americans with or without Crohn's disease or ulcerative colitis are eligible to join. If you agree to join the study, the investigators will ask for information about your health. The investigators will also ask you to give us a blood sample so that they may discover the genes that cause IBD. The blood sample may be collected at Johns Hopkins or any local facility convenient to you.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2003
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2003
CompletedFirst Submitted
Initial submission to the registry
June 16, 2010
CompletedFirst Posted
Study publicly available on registry
July 26, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
January 16, 2026
January 1, 2026
24.2 years
June 16, 2010
January 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
IBD Genes
Single visit, approximately 1 hour
Study Arms (2)
Affected
Patients with IBD
Unaffected
Individuals who do not have IBD
Eligibility Criteria
Individuals diagnosed with Inflammatory Bowel Disease
You may qualify if:
- African Americans with a confirmed diagnosis of Inflammatory Bowel Disease (IBD)
- African Americans without a diagnosis of IBD and without a family history of IBD for comparison purposes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21231, United States
Biospecimen
whole blood and derivatives from blood, saliva
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Lazarev, MD
Johns Hopkins University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 16, 2010
First Posted
July 26, 2010
Study Start
June 1, 2003
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share